Literature DB >> 24005140

The zebrafish embryo derivative affects cell viability of epidermal cells: a possible role in the treatment of psoriasis.

G D Norata1, P M Biava, F Di Pierro.   

Abstract

In patients affected by psoriasis, use of a topical formula containing a derivative of zebrafish embryos was associated with reduced skin inflammation and dermal turnover, as well as a generally better outcome. In an attempt to understand the molecular mechanisms lying beyond these findings, we investigated the anti-proliferative effects of the zebrafish embryos derivative by addressing the mitochondrial function (MTT assay) and cell nuclei distribution (Hoestch staining). In cell cultures stimulated with fetal calf serum (FCS) or epidermal growth factor (EGF), the zebrafish derivative significantly inhibited cell proliferation induced by either approach, although the effect was stronger in cells stimulated with FCS. These results suggest that the zebrafish embryos derivative may dampen increased cell proliferation; this observation may be relevant to cutaneous pathologies related to altered proliferative mechanisms, including psoriasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24005140

Source DB:  PubMed          Journal:  G Ital Dermatol Venereol        ISSN: 0392-0488            Impact factor:   2.011


  2 in total

Review 1.  Stem Cell Differentiation Stage Factors from Zebrafish Embryo: A Novel Strategy to Modulate the Fate of Normal and Pathological Human (Stem) Cells.

Authors:  Pier M Biava; Silvia Canaider; Federica Facchin; Eva Bianconi; Liza Ljungberg; Domenico Rotilio; Fabio Burigana; Carlo Ventura
Journal:  Curr Pharm Biotechnol       Date:  2015       Impact factor: 2.837

Review 2.  The Use of Stem Cell Differentiation Stage Factors (SCDSFs) Taken from Zebrafish Embryos during Organogenesis and Their Role in Regulating the Gene Expression of Normal and Pathological (Stem) Cells.

Authors:  Pier Mario Biava
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.